StockData
Pyxis Oncology, Inc. logo

Pyxis Oncology, Inc. (PYXS) stock

PYXSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/30
$1.44+0.03 (+2.13%)

Close on Nov 17, 2026Market cap $120.11MP/E –Yield –

Pyxis Oncology price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Pyxis Oncology's price to sales ratio was 7.7× on Apr 30, 2026.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Apr 30, 20267.7×+3.6
2025Apr 30, 20254.1×–

More Pyxis Oncology figures

See a number that looks wrong?